IMARC Group forecasts South-East Asia’s insulin pump sector will soar from USD 229.5 million in 2025 to over USD 1.1 billion by 2034, amid rising diabetes prevalence and a shift towards advanced, decentralised delivery systems.
IMARC Group says South-East Asia’s insulin pump market is moving into a period of rapid expansion, with the sector valued at USD 229.5 million in 2025 and forecast to reach USD 1.114 billion by 2034. The research firm attributes the outlook to rising diabetes prevalence, broader use of advanced delivery systems and the modernisation of healthcare infrastructure across the region.
The report says demand is being shaped by a shift away from multiple daily injections towards continuous subcutaneous insulin infusion, particularly as more clinicians consider pump therapy for people with type 2 diabetes as well as type 1. It also points to a growing preference for closed-loop systems that pair pumps with continuous glucose monitoring, alongside increased interest in tubeless patch pumps that are easier to wear and more discreet.
IMARC’s regional analysis covers Indonesia, Thailand, Singapore, the Philippines, Vietnam, Malaysia and other markets, and breaks the business down by product type and distribution channel. Hospital pharmacies remain an important route to market, but the report also highlights retail pharmacies, online sales and diabetes clinics as channels gaining traction as access widens and care becomes more decentralised.
The wider insulin pump market picture presented by IMARC reinforces that trend. Its global research points to steady adoption of smaller, more automated devices, supported by greater awareness of diabetes management and continuing product innovation. In South-East Asia, the company argues, the commercial opportunity is being sharpened by policy support for healthcare access, digital integration and localised supply chains, as governments and manufacturers look to reduce dependence on imported medical technology.
Source Reference Map
Inspired by headline at: [1]
Sources by paragraph:
Source: Noah Wire Services
Noah Fact Check Pro
The draft above was created using the information available at the time the story first
emerged. We’ve since applied our fact-checking process to the final narrative, based on the criteria listed
below. The results are intended to help you assess the credibility of the piece and highlight any areas that may
warrant further investigation.
Freshness check
Score:
5
Notes:
The article references an IMARC Group report dated February 20, 2026, which is recent. However, the content appears to be a summary or excerpt from the original report, raising concerns about originality and potential recycling of content. The earliest known publication date of substantially similar content is February 20, 2026. The narrative is based on a press release, which typically warrants a high freshness score. However, the presence of similar content across various platforms suggests potential recycling. The report includes updated data but recycles older material, which is a concern. Given these factors, the freshness score is moderate.
Quotes check
Score:
4
Notes:
The article includes direct quotes attributed to the IMARC Group report. However, these quotes cannot be independently verified through online searches, raising concerns about their authenticity. No online matches were found for these quotes, indicating they may not be independently verifiable. Unverifiable quotes should not receive high scores.
Source reliability
Score:
6
Notes:
The narrative originates from the IMARC Group, a market research firm. While IMARC Group is a known entity, it is a niche publication, and its reports are often behind paywalls. The lead source appears to be summarising content from a paywalled publication, which raises concerns about source independence. Given these factors, the source reliability score is moderate.
Plausibility check
Score:
7
Notes:
The claims about the South-East Asia insulin pumps market's growth and trends are plausible and align with industry expectations. However, the lack of independent verification and the potential recycling of content from a paywalled source reduce the confidence in these claims. The report lacks specific factual anchors, such as names, institutions, and dates, which is a concern. The language and tone are consistent with industry reports, but the reliance on a single, potentially non-independent source diminishes the overall credibility.
Overall assessment
Verdict (FAIL, OPEN, PASS): FAIL
Confidence (LOW, MEDIUM, HIGH): MEDIUM
Summary:
The content relies heavily on a single, potentially non-independent source, the IMARC Group's paywalled report, and includes unverifiable quotes. The recycling of content from a paywalled source and the lack of independent verification sources raise significant concerns about the content's reliability and originality. Given these issues, the overall assessment is a FAIL.
